Medicinal Cannabis Compounding Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 28
SKU : PH4052
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
What is the projected growth rate of the medicinal cannabis compounding market?
The medicinal cannabis compounding market is expected to reach a CAGR of 20.5% during the forecast period (2024-2031).
What are the major factors driving the growth of the market?
The growth of the market is driven by the proven medicinal properties of cannabis, legalization of cannabis in many countries, active research and development in the field, and advancements in intellectual property rights.
What are the different segments of the medicinal cannabis compounding market?
The market is segmented by product type (extracts, flowers, others), compound type (cannabidiol (CBD), tetrahydrocannabinol (THC), others), end-user (pharmaceutical industry, hospitals, clinics, others), and region (North America, Europe, Asia-Pacific, South America, Middle East & Africa).
Which region is expected to hold the largest share of the market?
North America is expected to hold the largest share of the market due to the increasing targeted population, prevalence of chronic disorders, and legalization of cannabis in many states and countries.